Speaker illustration

Doctor Abdul Waheed Khan

Monash University, Melbourne (Australia)

Dr. Khan is a National Heart Foundation funded Research Fellow within the Department of Diabetes, Monash University, Australia. He joined the Baker IDI Heart and Diabetes Research Institute in 2009 when he started his Master’s degree in the Vascular Biology and Atherosclerosis Laboratory and worked on the role of B2 B cells in atherosclerosis. He undertook his PhD on the role of MeCP2 in the silencing of the Norepinephrine transporter gene in Postural Tachycardia Syndrome (POTS) with Prof. El-Osta and a postdoctoral scholarship in the prestigious Karolinska Institute, Sweden and joined the research team of Prof. Francesco Cosentino. On his return to Australia, he Joined Daprtment of Diabetes, Monash University and have been working to identify novel therapeutic molecular targets for diabetes associated atherosclerosis.

Role of cFOS in mechanosensitive transcriptional regulation in diabetes associated atherosclerosis

Event: ESC Congress 2021 - The Digital Experience

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Advances in atherosclerosis research

Thumbnail

Single cell RNA sequencing identifies transcriptional signature of atherosusceptible endothelium of aorta in diabetes associated atherosclerosis

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Basic Science Vascular ePosters

Thumbnail

This platform is supported by

logo Novo Nordisk